Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.

Diabetes Care · 2011

Last updated 2026-07-12

Journal	Diabetes Care, 2011
Citations	267
Relative citation ratio	7.99
NIH percentile	96
Molecules	—
Conditions studied	Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease

Full record and abstract on PubMed 21525469 ↗